Hypothalamic-pituitary-adrenal axis activity in panic disorder: 24-Hour secretion of corticotropin and cortisol

Archives of General Psychiatry

Volumn 53, Issue 4, 1996, Pages 323-331

  Abelson, James L ^a   Curtis, George C ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN; HYDROCORTISONE;

ADULT; ARTICLE; BLOOD SAMPLING; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CONTROLLED STUDY; DISABILITY; DISEASE SEVERITY; FEMALE; HORMONAL REGULATION; HORMONE RELEASE; HUMAN; HYDROCORTISONE RELEASE; HYPERCORTISOLISM; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MALE; PANIC; PATHOPHYSIOLOGY;

EID: 0029916891     PISSN: 0003990X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archpsyc.1996.01830040059010     Document Type: Article

References (39)

1. Pihoker C, Nemeroff CB. The role of corticotropin-releasing factor in the pathophysiology of anxiety disorders. In: Hoehn-Saric R, McLeod DR, eds Biology of Anxiety Disorders. Washington, OC: American Psychiatric Press; 1993:103-119. Progress in Psychiatry series.
2. Roy-Byrne PP, Uhde TW, Post RM, Gallucci W, Chrousos GP, Gold PW. The corticotropin-releasing hormone stimulation test in patients with panic disorder. Am J Psychiatry 1986, 143 896-899.
3. Holsboer F, von Bardeleben U, Buller R, Heuser I, Steiger A. Stimulation response to corticotropin-releasing hormone (CRH) in patients with depression, alcoholism and panic disorder. Horm Metab Res. 1987;16(suppl) 80-88
4. Brambilla F, Bellodi L, Perna G, Battaglia M, Sciuto G, Diaferia G, Petraglia F, Panerai A, Sacerdote P. Psychoimmunoendocrine aspects of panic disorder. Neuropsychobiology. 1992;26.12-22.
5. Rapaport MH, Risch SC, Golshan S, Gillin JC. Neuroendocrine effects of ovine corticotropin-releasing hormone in panic disorder patients Biol Psychiatry. 1989; 26:344-348.
6. Coryell W, Noyes R HPA axis disturbance and treatment outcome in panic disorder. Biol Psychiatry. 1988;24:762-766
7. Curtis GC, Cameron OG, Nesse RM. The dexamethasone suppression test in panic disorder and agoraphobia. Am J Psychiatry. 1982;139 1043-1046.
8. Kathol RG, Anton R, Noyes R, Lopez AL, Reich JH Relationship of urinary free cortisol levels in patients with panic disorder to symptoms of depression and agoraphobia. Psychiatry Res. 1988;24:211-221
9. Uhde T, Joffe RT, Jimerson DC, Post RM. Normal urinary free cortisol and plasma MHPG in panic disorder: clinical and theoretical implications Biol Psychiatry. 1988;23:575-585
10. Goldstein S, Halbreich U, Asnis G, Endicott J, Alvir J. The hypothalamic-pituitary-adrenal system in panic disorder. Am J Psychiatry. 1987;144:1320-1323.
11. Lopez JF, Young EA, Herman JP, Akil H, Watson SJ Regulatory biology of the HPA axis: an integrative approach. In: Risch SC, ed. Central Nervous System Peptide Mechanisms in Stress and Depression Washington, DC: American Psychiatric Press; 1991.1-52.
12. Akil H, Morano MI The biology of stress: from periphery to brain. In Watson SJ, ed Biology of Schizophrenia and Affective Disease. Washington, DC: American Psychiatric Press. In press.
13. Charney DS, Heninger GR, Breier A Noradrenergic function in panic anxiety: effects of yohimbine in healthy subjects and patients with agoraphobia and panic disorder Arch Gen Psychiatry. 1984;41.751-763
14. Meador-Woodruff JH, Haskett RF, Grunhaus L, Akil H, Watson SJ, Greden JF. Postdexamethasone plasma cortisol and B-endorphin levels in depression: relationship to severity of illness. Biol Psychiatry. 1987,22.1137-1150.
15. Veldhuis JD, Iranmanesh A, Johnson ML, Lizarralde G. Twenty-four-hour rhythms in plasma concentrations of adenohypophyseal hormones are generated by distinct amplitude and/or fequency modulation of underlying pituitary secretory bursts. J Clin Endocrinol Metab. 1990;71 1616-1623
16. Spitzer RL, Williams JBW. Structured Clinical Interview for DSM-III-R Upjohn Version-Revised. New York, NY: Biometrics Research Dept. New York State Psychiatric Institute; 1986.
17. Ballenger J, Burrows G. DuPont RJ, Lesser I, Noyes RJ, Pecknold J, Rifkin A, Swinson R. Alprazolam in panic disorder and agoraphobia: results from a multicenter trial, I. efficacy in short-term treatment. Arch Gen Psychiatry. 1988; 45:413-422
18. Teicher MH, Barber NI. COSIFIT: an interactive program for simultaneous multioscillator cosinor analysis of time-series data Comput Biomed Res. 1990; 23.283-295.
19. Veldhuis JD, Iranmanesh A, Lizarralde G, Johnson ML Amplitude modulation of a burstlike mode of cortisol secretion subserves the circadian glucocorticoid rhythm. Am J Physiol. 1989;257.E6-E14.
20. Kushler RH, Brown MB. A model for the identification of hormone pulses. Stat Med. 1991;10 329-340
21. Roelfsema F, Van Den Berg G, Frölich M, Veldhuis JD, Van Eijk A, Buurman MM, Etman BHB. Sex-dependent alterations in cortisol response to endogenous adrenocorticotropin. J Clin Endocrinol Metab 1993;77:234-240.
22. Abelson JL, Curtis GC Discontinuation of alprazolam after successful treatment of panic disorder: a naturalistic follow-up study. J Anxiety Disord. 1993; 7:107-117
23. Linkowski P, Medlewicz J, Leclercq R, Brasseur M, Hubain P, Golstein J, Copinschi G, Van Cauter E. The 24-hour profile of adrenocorticotropin and cortisol In major depressive illness J Clin Endocrinol Metab. 1985,61.429-438.
24. Halbreich U, Asnis GM, Shindledecker R, Zumoff B, Nathan RS Cortisol secretion in endogenous depression, II: time-related functions. Arch Gen Psychiatry 1985,42.909-914.
25. 1-24) stimulation in major depression: relationship to dexamethasone suppression test results. Arch Gen Psychiatry 1987,44:233-240.
26. Nemeroff CB, Krishnan KRR, Reed D, Leder R, Beam C, Dunnick NR. Adrenal gland enlargement in major depression: a computed tomographic study. Arch Gen Psychiatry. 1992;49:384-387.
27. Yehuda R, Boisoneau D, Mason JW, Giller EL. Glucocorticoid receptor number and cortisol excretion in mood, anxiety, and psychotic disorders. Biol Psychiatry. 1993,34:18-25.
28. Dallman MF, Akana SF, Scnbner KA, Bradbury MJ, Walker C-D, Strack AM, Cascio CS. Stress, feedback, and facilitation in the hypothalamic-pituitary-adrenal axis. J Neuroendocrinol. 1991,4:517-526.
29. Späth-Schwalbe E, Gofferje M, Kern W, Born J, Fehm HL. Sleep disruption alters nocturnal ACTH and cortisol secretory patterns. Biol Psychiatry. 1991, 29:575-584.
30. Fehm HL, Spath-Schwalbe E, Pietrowsky R, Kern W, Born J Entrainment of nocturnal pituitary-adrenocortical activity to sleep processes in man: a hypothesis Exp Clin Endocrinol 1993, 101 267-276.
31. Cameron OG, Lee MA, Curtis GC, McCann DS. Endocrine and physiological changes during 'spontaneous' panic attacks. Psychoneuroendocrinology. 1987, 12:321-331.
32. Carr DB, Sheehan DV, Surman OS. Coleman JH, Greenblatt DJ, Heninger GR, Jones KJ, Levine PH, Watkins WD. Neuroendocrine correlates of lactateinduced anxiety and their response to chronic alprazolam therapy. Am J Psychiatry. 1986;143:483-494.
33. Coryell W, Noyes R, Schlechte J. The significance of HPA axis disturbance in panic disorder. Biol Psychiatry. 1989;25.989-1002.
34. Linkowski P, Medlewicz J, Kerkhofs M, Leclercq R, Golstein J, Brasseur M, Copinschi G, Van Cauter E. 24-Hour profiles of adrenocorticotropin, cortisol, and growth hormone in major depressive illness, effect of antidepressant treatment J Clin Endocrinol Metab 1987,65:141-152
35. Coryell W, Noyes R, Reich J. The prognostic significance of HPA-axis disturbance in panic disorder: a 3-year follow-up. Biol Psychiatry. 1991;29:96-102.
36. Kathol RG, Anton R, Noyes R, Gehris T. Direct comparison of urinary free cortisol excretion in patients with depression and panic disorder. Biol Psychiatry. 1989;25:873-878.
37. Lopez AL, Kathol RG, Noyes R. Reduction in urinary free cortisol during benzodiazepine treatment of panic disorder. Psychoneuroendocrinology. 1990;15:23-28.
38. Gurguis GNM, Mefford IN, Uhde TW Hypothalamic-pituitary-adrenocortical activity in panic disorder. relationship to plasma catecholamine metabolites Biol Psychiatry 1991:30.502-506.
39. Axelrod J, Reisine TD, Stress hormones. their interaction and regulation Science 1984,224:452-459.